Display Settings:

Format
Items per page

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 6

1.

Herpes Zoster Vaccine

An attenuated vaccine used to prevent and/or treat HERPES ZOSTER, a disease caused by HUMAN HERPESVIRUS 3. [from MeSH]

MedGen UID:
354539
Concept ID:
C1720918
Pharmacologic Substance
2.

Herpes zoster

An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) [from MeSH]

MedGen UID:
42437
Concept ID:
C0019360
Disease or Syndrome
3.

Vaccines

Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response. Vaccines range from inactivated or attenuated microorganisms (bacteria and viruses), enhanced autologous tumor cells, tumor antigens or epitopes that are used to elicit host immune responses. Vaccines are used for the prevention, amelioration, or treatment of infectious diseases and cancer. [from NCI]

MedGen UID:
52963
Concept ID:
C0042210
Pharmacologic Substance
4.

Herpes NOS

Any inflammatory skin disease caused by a herpesvirus and characterized by the formation of small vesicles in clusters. [from NCI]

MedGen UID:
6821
Concept ID:
C0019340
Disease or Syndrome
5.

Zostavax

MedGen UID:
318606
Concept ID:
C1720919
Pharmacologic Substance
6.

MedGen UID:
182674
Concept ID:
C0947706

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...